5J9-28451-45615
2 vaccinations
0 coded responses
24 check-ins
0 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 551 / MN
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Pfizer-BioNTech
- 2021-04-03
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-04-05
- 2021-04-06
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitAdult check-in
-
2021-04-08
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-09
-
2021-04-10
Call successfulParticipant prefers to complete VAERS report online
- 2021-04-12
- 2021-04-17
-
2021-04-24
Dose 2 — Pfizer-BioNTech
- 2021-04-24
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body achesAdult check-in
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
- 2021-05-01
- 2021-05-08
- 2021-05-15
- 2021-05-22
- 2021-05-29
- 2021-06-05
- 2021-07-26
- 2021-10-23
- 2022-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Pfizer-BioNTech | |
| 2 | 2021-04-24 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-04 | priority 2/3 | |
| 2021-04-08 | Successful 2021-04-10 |
Participant prefers to complete VAERS report online |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.